OTC Markets OTCPK - Delayed Quote USD
Entia Biosciences, Inc. (ERGO)
0.0001
0.0000
(0.00%)
At close: June 12 at 8:00:00 PM EDT
Breakdown
TTM
Total Revenue
265.4660
Cost of Revenue
91.4990
Gross Profit
173.9670
Operating Expense
1,341.3460
Operating Income
-1,167.3790
Net Non Operating Interest Income Expense
-83.5120
Other Income Expense
-144.8910
Pretax Income
-1,395.7820
Net Income Common Stockholders
-1,395.7820
Diluted NI Available to Com Stockholders
-1,395.7820
Basic EPS
-0.05
Diluted EPS
-0.05
Basic Average Shares
28,136.5270
Diluted Average Shares
28,136.5270
Total Operating Income as Reported
-1,310.3480
Total Expenses
1,432.8450
Net Income from Continuing & Discontinued Operation
-1,395.7820
Normalized Income
-1,257.5210
Interest Expense
83.5120
Net Interest Income
-83.5120
EBIT
-1,312.2700
EBITDA
-1,294.5730
Reconciled Cost of Revenue
91.4990
Reconciled Depreciation
17.6970
Net Income from Continuing Operation Net Minority Interest
-1,395.7820
Total Unusual Items Excluding Goodwill
-138.2610
Total Unusual Items
-138.2610
Normalized EBITDA
-1,156.3120
Tax Rate for Calcs
0
Tax Effect of Unusual Items
0
8/3/57423 - 1/18/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GXE.F Galapagos NV
24.76
+0.08%
BT3.BE Lineage Cell Therapeutics Inc
0.5850
-0.85%
AB3A.MU Sarepta Therapeutics Inc
31.82
-1.18%
LVCLF Algorae Pharmaceuticals Limited
0.0054
0.00%
ITRX inTerra Resources Corp
0.0240
0.00%
GENSY Genus plc
24.34
0.00%
8QQ.BE AbCellera Biologics Inc
2.5800
-6.99%
AVXT AVAX Technologies, Inc.
0.0000
0.00%
T3X.BE Telix Pharmaceuticals Ltd
13.93
-5.63%
AYJ.HA Valneva SE
2.6180
-4.10%